Europe Customized Premix Market segmented By Nutrient (Minerals, Vitamins, Nutraceuticals, Amino Acids and Nucleotides), Application (Dairy, Beverages, Bakery & Confectionery, Nutrition Products, Cereals and Dietary Supplements), Functionality (Bone Health, Skin Health, Energy, Immunity and Digestion), And Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Size, Share, Trends, Growth, Forecast (2025 to 2033)
Europe Customised Premix Market size was calculated to be USD 0.60 billion in 2024 and is anticipated to be worth USD 1.13 billion by 2033, from USD 0.64 billion in 2025, growing at a CAGR of 7.37% during the forecast period.
Customised premix is a precisely formulated blend of vitamins, minerals, amino acids, and functional ingredients tailored to meet the specific nutritional requirements of target populations, animal species, or food and feed applications. Unlike standard premixes, these are engineered based on regional dietary gaps, health regulations, raw material compatibility and end product stability. According to Eurostat, 21.6% of the EU population was aged 65 or older in 2024, which is intensifying demand for age-specific human nutrition premixes. Micronutrient inadequacy remains a significant issue across Europe, with widespread deficiencies in vitamin D, B12 and iron despite adequate caloric intake. Additionally, the European Union produced 147 million tons of compound feed in 2024, which requires species and life-stage-specific premixes to comply with the EU Animal Nutrition Regulation. These demographic and regulatory realities position customised premixes as essential tools for public health and agricultural productivity.
The European population exhibit subclinical micronutrient deficiencies, which is creating sustained demand for targeted premixes in fortified foods and dietary supplements and is one of the key factors propelling the growth of the customised premix market in Europe. According to the European Food Safety Authority, many adults in Northern and Western Europe have serum vitamin D levels below 50 nanomoles per litre, particularly during winter months. Similarly, as per the European Micronutrient Recommendations Aligned project, a substantial share of women of childbearing age have insufficient folate status, increasing neural tube defect risks. These gaps have prompted national and industry fortification initiatives as several European countries encourage folic acid fortification of staple foods, and the UK has widespread voluntary vitamin D fortification in dairy alternatives. Custom premix manufacturers respond by developing stable heat-resistant blends that survive baking or pasteurisation. For instance, fortified milk with tailored vitamin D and calcium premixes can help maintain or improve bone mineral density in elderly subjects over 12 months. This convergence of epidemiological evidence, policy action, and clinical validation ensures robust demand for scientifically formulated human nutrition premixes.
The European Union enforces highly specific regulations on the use of vitamins and minerals in animal feed under Regulation EC 1831 2003 and subsequent amendments, which directly fuels demand for compliant customised premixes and drives the regional market expansion. According to the European Union Register of Feed Additives, only authorised substances may be used in feed with strict maximum inclusion levels defined per species and production stage. For example, high-dose medicinal zinc oxide was withdrawn in 2022, and nutritional zinc in piglet feed is limited to 150 mg/kg, which requires nutritionists to formulate alternative premixes with organic trace minerals and phytogenic. Premixes are widely used across EU compound feed to ensure legal compliance and performance optimisation. Furthermore, the Farm to Fork Strategy’s 2030 target of reducing antimicrobial use by 50% has accelerated the adoption of immune-supporting premixes containing selenium, vitamin E and organic acids. These regulatory and sustainability imperatives transform premix formulation from a nutritional exercise into a legal necessity, driving continuous innovation in stability, delivery and traceability.
The Europe Customised Premix Market presents significant financial and technical barriers for small and medium enterprises due to the cost of regulatory compliance and quality assurance. According to the European Commission’s SME Strategy Unit, preparing a single EFSA dossier for a novel feed additive is costly and typically takes between 1 and 2 years to approve. Even for established vitamins and minerals, manufacturers must maintain full traceability from raw material origin to final blend as mandated by Regulation EC 183 2005 on feed hygiene. Many small premix formulators outsource testing for heavy metals, mycotoxins, and microbial contamination, and such testing can cost several thousand euros per batch. Additionally, the volatility of key ingredients strains working capital. These combined pressures limit market entry to well-capitalised players with in-house regulatory and analytical capabilities and thereby reducing competition and innovation from agile niche formulators.
Despite EU harmonisation efforts, significant discrepancies remain in the implementation of nutrient labelling and health claim regulations across member states, complicating premix design for pan-European brands, which is further hampering the growth of the European customised premix market. National authorities in Europe apply divergent interpretations of the Nutrition and Health Claims Regulation EC 1924 2006 regarding permissible nutrient levels in fortified foods. For instance, a calcium fortified beverage compliant in one member state may exceed maximum levels allowed in another due to differing reference intakes. This forces manufacturers to develop multiple premix formulations for the same product line, increasing inventory and validation costs. Multinational food companies often maintain multiple region-specific premix variants for a single cereal product to align with local nutrient upper limits. Until the European Commission enforces truly unified nutrient profiling and labelling standards, ds formulation complexity will remain a persistent operational and compliance burden for premix suppliers.
The rise of DNA-based and biomarker-driven personalised nutrition is opening a high-margin segment for micro-batch customised premixes in Europe, which is one of the promising opportunities for the European customised premix market. Across the EU, numerous personalised nutrition startups were active in 2024 and offering tailored vitamin and mineral blends based on genetic or metabolic data. These platforms require premix manufacturers to produce small lots with precise ratios of bioavailable forms, such as methylcobalamin instead of cyanocobalamin or cholecalciferol over ergocalciferol. The European personalised nutrition market is projected to reach several billion euros by 2027, which is creating demand for flexible manufacturing and rapid reformulation capabilities. Companies like Switzerland’s Rootine and Germany’s Lykon have partnered with certified premix blenders who operate GMP-compliant micro blending suites with full documentation for EFSA-aligned health substantiation. This shift transforms premixes from bulk commodities into precision health components aligned with Europe’s preventive healthcare agenda.
The surge in plant-based food and beverage innovation is driving demand for customised premixes that use natural-derived and clean-label-compliant nutrients, which is another potential opportunity for the European market. Sales of plant-based dairy and meat alternatives grew in 2024, with fortification being an important purchase driver for consumers. However, traditional synthetic vitamins like dl alpha tocopherol or cyanocobalamin are increasingly rejected by clean-label standards. In response, premix formulators are sourcing natural vitamin E from sunflower oil, vitamin B12 from fermented chickpea broth and vitamin D2 from UV-exposed mushrooms. The European Commission’s updated guidance on natural flavourings now includes criteria for fermentation-derived nutrients, facilitating regulatory acceptance. For instance, oat milk fortified with natural source premixes retains higher nutrient stability after UHT processing compared to synthetic versions. This alignment of consumer preference, technical performance and regulatory evolution positions natural premixes as a strategic growth vector.
The Europe Customised Premix Market faces recurring disruptions due to reliance on globally sourced speciality ingredients with limited alternative suppliers. According to the European Chemicals Agency, a significant share of high-purity pyridoxine hydrochloride and folic acid used in EU premixes is sourced from China and India. Geopolitical tensions, export restrictions and logistical bottlenecks have created volatility, as reports in 2024 noted longer lead times for critical B vitamins compared to 2021. Furthermore, the EU’s Novel Food rules can require reapproval when sourcing changes or new production methods are introduced, even if the ingredient is chemically identical, increasing reformulation risk. A 2024 incident involving contaminated beta carotene from a secondary supplier led to recalls of fortified cereal brands across multiple EU countries, as documented by the Rapid Alert System for Food and Feed. Without diversified sourcing or regional fermentation capacity for key vitamins, Europe’s premix industry remains vulnerable to supply shocks that compromise both safety and continuity.
The lack of specialised nutritional and regulatory knowledge among small and medium food and feed producers is further challenging the expansion of the European customised premix market. These companies often select premixes based on cost or generic formulations without considering bioavailability ingredient interactions or processing stability. An audit by a German agricultural authority noted that many small dairy processors used premixes containing iron and vitamin C together in UHT milk, which is a combination that can accelerate oxidative rancidity due to pro-oxidant effects. Similarly, in animal feed, a notable share of small pig farms in Southern Europe used off-the-shelf premixes not adjusted for local cereal mycotoxin levels, reducing mineral absorption. This knowledge gap leads to suboptimal efficacy, product recalls and regulatory non-compliance. Until comprehensive extension services or digital formulation tools become widely accessible, the full potential of customised premixes will remain underutilised across Europe’s fragmented manufacturing landscape.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 7.37% |
| Segments Covered | By Nutrient, Application, Functionality and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, and the Czech Republic |
| Market Leaders Profiled | Vitablend, Glanbia plc, DSM, Corbion, Arla, Stern Vitamins GmbH, Watson, The Wright Group, Cargill, and Farbest Brands |
The vitamins segment captured the largest share of 41.4% of the European customised premix market in 2024. The dominance of the vitamins segment in the European market is driven by its widespread subclinical deficiencies and extensive regulatory endorsement of fortification. EFSA maintains a framework for authorised nutrition and health claims, including vitamin D for bone health and B vitamins for energy metabolism. For instance, a high prevalence of vitamin D insufficiency in Northern Europe during winter is prompting national fortification initiatives in dairy and plant-based alternatives. EU guidance encourages measures to reduce neural tube defects, and some countries have considered or implemented folic acid fortification policies. These epidemiological and policy drivers ensure vitamins remain the cornerstone of premix formulation across human and animal nutrition.
The nutraceuticals segment is expected to witness a CAGR of 9.7% over the forecast period, owing to the rising consumer demand for functional benefits beyond basic nutrition and evolving regulatory pathways. Sales of products containing plant sterols, polyphenols, and omega-3 concentrates grew in 2024, with customised premixes enabling stable incorporation into foods. The European Food Safety Authority has issued positive opinions on several nutraceuticals, including olive polyphenols for cardiovascular protection and lutein for eye health, creating legally defensible claims. In response, premix formulators are developing microencapsulated or lipid-based delivery systems to protect sensitive compounds during processing. A recent pilot demonstrated that a premix containing standardised olive polyphenols per serving met EFSA’s claim criteria while surviving UHT treatment in milk. Additionally, EU research programs allocated funding in 2024 to projects validating the efficacy of food-grade nutraceuticals in chronic disease prevention, further legitimising their inclusion in mainstream fortified products.
The dietary supplements segment held 30.7% of the European market share in 2024. The leading position dietary supplements segment in the European market is attributed to the high consumer reliance on capsules, tablets and powders to address micronutrient gaps not met through diet alone. According to consumer surveys, a substantial share of EU adults regularly use multivitamins or single-nutrient supplements, with demand notably high among older adults and performance-focused consumers. The European Medicines Agency permits higher nutrient levels in supplements than in foods, enabling more potent premixes tailored to specific health goals such as bone support or immune resilience. National health systems also influence usage. In some countries, insurance coverage and public health programs support vitamin D and calcium for osteoporosis prevention. Moreover, the rise of private label supplement brands in retail chains like dm Drogerie and Boots has increased demand for flexible premix solutions that support rapid product differentiation. These factors collectively make dietary supplements the highest value and most formulation-intensive application segment.
The plant-based beverages segment is the fastest-growing application segment with a CAGR of 12.2% over the forecast period, owing to the convergence of dairy alternatives and nutritional fortification expectations. Sales of oat, so,y and almond beverages grew in 2024, with many consumers citing added vitamins and minerals as a key purchase factor. Unlike dairy, which naturally contains calcium and B, plant-based products require customised premixes to match nutritional parity. However, synthetic nutrients are increasingly rejected as manufacturers now demand premixes with natural source vitamin D2 from UV-exposed mushrooms, calcium from algae and B12 from fermented chickpea broth. Studies have shown that premixes using these natural forms can retain high stability after UHT processing compared to synthetic variants. Regulatory alignment also helps, as recent EU guidance on natural nutrient sources facilitates clean label claims. This perfect storm of health demand, clean label pressure, and technical innovation is accelerating premix adoption in this dynamic category.
The immunity segment led the market by accounting for 29.1% of the European market in 2024 due to the sustained consumer awareness and scientific validation of key nutrients in immunodeficiency. The European Food Safety Authority has authorised health claims for vitamins C, D, and zinc, stating they contribute to the normal function of the immune system. For instance, many adults in France, Germany and Sweden actively seek products fortified with immune-supporting nutrients. The post-pandemic health consciousness remains elevated. Vitamin D supplement sales in Germany have remained above pre-2020 levels in 2024. Additionally, the EU’s Farm to Fork Strategy targets a 50% reduction of antibiotic use in livestock by 2030, which has driven demand for immune premixes in animal feed containing selenium, vitamin E and organic acids. This dual human and animal health imperative ensures immunity remains the most commercially significant functional category.
The bone health segment is a prominent segment and is estimated to grow at a CAGR of 9.7% over the forecast period in the European customised premix market due to ageing demographics and policy-driven osteoporosis prevention initiatives. According to Eurostat, 21.6% of the EU population was aged 65 or older in 2024, with the share expected to rise further in the coming years. According to the estimations of the International Osteoporosis Foundation, around 32 million people aged 50+ in Europe have osteoporosis, with osteoporosis-related fractures costing health systems an estimated 56.9 billion euros annually. In response, national programs are promoting fortification, as Finland has long implemented vitamin D fortification in liquid dairy products and spreads, while the UK’s National Health Service recommends daily vitamin D supplementation for older adults. Custom premixes now combine vitamin D3,3, calcium, magnesium and vitamin K2 to support bone health. These clinical and policy drivers are transforming bone health from a niche concern into a mainstream public health priority reflected in fortified foods, beverages, and supplements.
Germany led the Europe customised premix market with a 20.2% of the regional market share in 2024, owing to its robust supplement culture, strict quality standards and ageing population. According to the German Federal Institute for Risk Assessment, many adults use vitamin and mineral supplements regularly, with immunity and bone health being top concerns. The country enforces some of the EU’s most rigorous requirements for nutrient stability and labelling under the German Food Cod,e Lebensmittelbuch, ensuring high specification premix demand. Additionally, Germany’s statutory health insurance system can support certain fortified or supplemented products for at-risk groups, creating a quasi-pharmaceutical channel. Major manufacturers like Bayer and Merck operate large-scale premix blending facilities in Bavaria and Hesse, serving both domestic and export markets. These structural advantages position Germany as both the largest consumption hub and a formulation benchmark for the broader European market.
The United Kingdom is another prominent market for customised premixes in Europe and is expected to account for a substantial share of the regional market over the forecast period, owing to the national fortification policies and a thriving private label supplement sector. The UK government will mandate folic acid fortification of non‑wholemeal wheat flour from 2026 to help prevent birth defects. The National Health Service advises adults to consider daily vitamin D supplementation during autumn and winter, driving demand for stable D3 and K2 premixes in dairy and plant alternatives. Retailers like Boots and Holland and Barrett operate extensive private label supplement lines requiring agile premix partners for rapid formulation. Additionally, the UK’s post‑Brexit regulatory autonomy enables independent approval pathways for novel nutrient forms. These policies and commercial dynamics make the UK a high-velocity market for both human and functional animal nutrition premixes.
France is predicted to hold a prominent share of the Europe customised premix market over the forecast period owing to its strong dairy industry and public health nutrition programs. As per FranceAgriMer, many yoghurts and dairy desserts sold in France are fortified with vitamins D and B1,2, requiring customised premixes compatible with fermentation and cold chain stability. The National Nutrition and Health Program PNNS mandates the reduction of salt and sugar while encouraging micronutrient fortification, creating dual formulation challenges. The French Agency for Food, Environmental and Occupational Health and Safety, ANSES, has published multiple dossiers since 2020 supporting the safety of specific nutrient combinations in foods. Additionally, France is a leader in functional animal feed with a large pig sector requiring stage-specific premixes to comply with the EU’s antibiotic reduction directive. These agricultural and public health imperatives ensure sustained high-volume demand across multiple application segments.
Italy is expected to exhibit a healthy CAGR in the European customised premix market during the forecast period, owing to the Mediterranean diet gaps and a large ageing population. According to ISTAT, 23.4% of Italians were aged 65 or older in 2024, one of the highest shares in the EU, driving demand for bone and cognitive health premixes. Despite high olive oil and vegetable consumption, studies report widespread vitamin D deficiencies among Italians, largely due to limited dairy and fish intake. In response, major pasta and cereal manufacturers have launched fortified lines using heat-stable premixes that survive extrusion and baking. Italy’s National Prevention Plan 2020–2025 encourages food fortification as a cost-effective public health tool. Additionally, Italy’s large poultry and pig sectors require EU-compliant feed premixes with organic trace minerals following the 2022 ban on veterinary zinc oxide in pig production. These intersecting human and animal nutrition needs create a diverse and resilient premix market.
The Netherlands is projected to showcase a notable CAGR in the Europe customised premix market over the forecast period due to its strength rooted in agri-food innovation and export-oriented production. According to the Dutch Nutrition Centre, over 70% of plant-based dairy alternatives produced in the country are fortified with customised premixes containing natural source vitamins to meet EU and global clean label standards. The Netherlands is Europe’s largest exporter of compound feed, requiring species-specific premixes compliant with EU regulations for shipment to over 120 countries. The government’s Top Sector AgriFood program has invested significant funding in nutrient delivery technologies, including microencapsulation for premix stability. Companies like FrieslandCampina and DSM operate advanced R&D centres in Wageningen, developing premixes validated in real food matrices. This fusion of scientific rigour, regulatory expertise and global trade orientation positions the Netherlands as a key innovation and logistics hub for the European premix industry.
The Europe Customised Premix Market features intense competition among multinational nutrition companies with integrated capabilities in ingredient synthesis, application science, and regulatory affairs. Differentiation is driven by bioavailability data processing stability, clean label credentials, and digital support tools rather than price alone. Incumbents leverage decades of EFSA dossier experience and in-house stability testing to maintain trust with large food and feed manufacturers. However, the market is increasingly segmented with niche players focusing on natural nutrients, personalised blends or alternative protein compatibility. High barriers to entry—including GMP compliance, analytical validation and traceability infrastructurefavourr established players. Nevertheless, rising demand for tailored solutions in in-plant-based foods and precision animal nutrition is creating opportunities for agile formulators who combine scientific rigour with formulation flexibility. Consolidation remains moderate as buyers value vendor diversification for risk mitigation in the critical nutrient supply.
A few major players of the Europe customised premix market include
Key players in the Europe Customised Premix Market prioritise regulatory alignment by ensuring formulations meet EFSA nutrient limits and health claim requirements across all member states. They invest in application technology centres to validate premix stability during real-world processing, such as baking extrusion, and UHT treatment. Companies increasingly develop natural and fermentation-derived nutrient sources to support clean label trends in inplant-basedd and premium foods. Strategic partnerships with food manufacturers and retailers enable co-development of functional products with defensible health positioning. Lastly, they deploy digital formulation tools and traceability platforms to enhance batch consistency, regulatory documentation and supply chain transparency in response to EU food safety directives.
DSM-Firmenich is a leading force in the European Customised Premix Market, offering science-driven vitamin, mineral and nutraceutical blends for human and animal nutrition. The company leverages its extensive R&D infrastructure in the Netherlands and Switzerland to develop stable bioavailable formulations compliant with EFSA and EU feed regulations. In 2024, DSM-Firmenich launched a new line of natural source premixes using vitamin D2 from UV-treated mushrooms and B12 from chickpea fermentation, specifically for clean-label plant-based foods. It also enhanced its digital formulation platform, allowing customers to simulate nutrient stability during thermal processing. These innovations reinforce its global reputation as a trusted partner for high-integrity, customised nutrition solutions across food, pharma and feed sectors.
BASF SE plays a pivotal role in the Europe Customised Premix Market through its human nutrition and animal health divisions, providing tailored vitamin and carotenoid premixes. Headquartered in Germany, the company combines chemical synthesis expertise with application technology centres across Europe to ensure premix performance in real food matrices. In recent years, BASF has strengthened its position by expanding its microencapsulation capabilities in Ludwigshafen to protect sensitive nutrients, omega-3s 3s and probiotics during baking and extrusion. In early 2025, it introduced a bone health premix combining vitamin D3, K2 and magnesium optimised for dairy and cereal applications. These actions underscore BASF’s commitment to functional stability and regulatory compliance in high-growth health segments.
Adisseo France SAS is a key contributor to the European Customised Premix Market, specialising in animal nutrition with a growing portfolio in human functional ingredients. The company operates advanced blending facilities in France and Spain, producing species and life-stage-specific premixes that comply with the EU’s stringent feed additive regulations. In 2024, Adisseo launched a next-generation immune support premix for piglets featuring organic trace minerals and phytogenics following the EU-wide ban on zinc oxide. It also partnered with European research institutes to validate the bioavailability of its amino acid and vitamin blends in alternative protein feeds. These initiatives position Adisseo as an innovation leader in sustainable and precision animal nutrition with increasing crossover into human health applications.
This research report on the Europe customised premix market has been segmented and sub-segmented based on nutrient, application, functionality and region.
By Nutrient
By Application
By Functionality
By Region
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region